Midtown is a neighborhood of Houston, Texas. Semaglutide is a GLP-1 receptor agonist FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. In a city built on rotating shifts - energy operations, the Texas Medical Center, refineries and round-the-clock hospitality - many Houston workers struggle to reach a daytime clinic. Telehealth removes that barrier: a licensed Texas physician reviews your online health assessment under Texas Occupations Code §111.001, and compounded semaglutide from an FDA-registered 503B pharmacy ships overnight to your Houston address. Monthly cost runs $199–$379 versus roughly $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. David Park, MD, Board-Certified Internal Medicine & Obesity Medicine. Serving Houston ZIP codes: 77001, 77002, 77003, 77004, 77005.
Yes. Under Texas Occupations Code §111.001, a physician licensed in Texas may prescribe weight-management drugs including semaglutide through live video or store-and-forward telehealth. The Texas Medical Board regulates these providers at tmb.state.tx.us. No prior in-person visit is required to begin treatment, which is why so many Houston shift workers can start care online.
Yes. A Houston resident can complete an online health assessment and, if appropriate, receive a Semaglutide prescription within 24 to 48 hours - no clinic trip. The prescriber must hold a Texas license and follow Texas Occupations Code §111.001. For energy and medical-center workers, this means care that fits between rotations.
The Texas Medical Board (tmb.state.tx.us) requires telehealth clinicians serving Houston patients to keep full Texas licensure, document each encounter and obtain informed consent. Compounded Semaglutide must come from an FDA-registered 503B outsourcing facility. These safeguards apply equally whether you consult at noon or at 3 a.m.
No. Texas Occupations Code §111.001 allows prescribing without a prior face-to-face relationship for patients across Houston and Texas. A video consult or reviewed questionnaire meets the standard of care under Texas Medical Board rules - a practical fit for workers who can't reach a daytime office.
Yes. Any licensed provider serving Houston must comply with HIPAA: encrypted transmission of your records, signed agreements with pharmacy partners, and tight limits on who can see your health information. Your data is protected the same way a Houston hospital protects it.
Brand-name GLP-1 drugs (Ozempic, Wegovy) average about $1,247/month at Houston pharmacies per GoodRx data. Compounded semaglutide through telehealth - made under 503B standards - typically runs $199–$379/month including the prescription, with no separate clinic fee eating into a tight shift-work budget.
It depends on the plan. Medicare Part D covers Ozempic for diabetes but not Wegovy for weight loss, and most commercial plans want prior authorization plus a qualifying BMI. Many Houston patients skip the paperwork and weeks of delay by paying cash for compounded semaglutide at $199–$379/month.
Houston residents without coverage, or with high-deductible plans common in contract and energy work, increasingly choose compounded semaglutide through telehealth. Cash pricing of $199–$379/month compares with about $1,247/month retail for branded versions - predictable cost with no prior-auth surprises.
In-person weight clinics in Houston typically charge 150 to 300 dollars per visit on top of medication. A telehealth program at $199–$379/month removes travel, parking near the Medical Center, and repeat visit fees - a real saving for patients out in ZIP codes like 77001, 77002, 77003, 77004, 77005 or on rotations far from town.
Options for Houston residents include Novo Nordisk savings cards for eligible insured patients, compounded semaglutide at $199–$379/month via telehealth, and 340B pricing at federally qualified health centers. With a Houston median household income near 58,929 dollars and Texas's uninsured rate at 16.6%, cash-friendly access matters here.
Semaglutide mimics GLP-1, a gut hormone released after eating. It prompts insulin when glucose is high, dials down glucagon, slows stomach emptying so you feel full longer, and quiets appetite signals in the brain. Together these effects drive steady, lasting weight loss - helpful when irregular Houston schedules make disciplined eating hard.
Semaglutide (Ozempic, Wegovy) is a single-pathway GLP-1 agonist approved for weight management in 2021. Tirzepatide (Mounjaro, Zepbound) hits both GLP-1 and GIP receptors and showed greater average loss - about 22.5 percent in SURMOUNT-1 versus 14.9 percent for semaglutide in STEP-1. Both are available to Houston patients by telehealth.
Wegovy (semaglutide 2.4 mg weekly) was FDA-approved in June 2021 for adults with a BMI of 30 or higher, or 27 with a related condition. Ozempic (semaglutide) is approved for type 2 diabetes. Compounded semaglutide is produced under Section 503B of the FD&C Act and dispensed by registered facilities.
In STEP-1 (New England Journal of Medicine, 2021), adults on semaglutide 2.4 mg weekly lost an average of 14.9 percent of body weight over 68 weeks versus 2.4 percent on placebo. STEP-4 found that stopping the drug led to regain - which is why Houston clinicians frame it as ongoing treatment, not a quick course.
FDA labeling covers adults with a BMI of 30 or higher, or 27 or higher with a condition such as high blood pressure, type 2 diabetes or high cholesterol. Telehealth providers serving Houston apply the same criteria, confirmed through your online assessment and medical history.
Most licensed providers serving Houston require a BMI of 27 or higher with a related condition like prediabetes or hypertension, or 30 or higher on its own. Self-reported height and weight are accepted for initial screening; the reviewing physician may request confirmation.
The common side effects reported by more than one in ten trial participants are nausea, vomiting, diarrhea, constipation and abdominal discomfort, usually worst during dose increases. Rare serious risks include pancreatitis and gallbladder problems. Your prescriber reviews contraindications, including personal or family history of medullary thyroid cancer, during the consult.
Typical pre-treatment labs include a comprehensive metabolic panel, complete blood count, HbA1c, lipid panel and TSH. Many telehealth providers accept recent results from a primary care doctor. Houston patients can use nearby Quest or LabCorp draw sites, including locations near the Texas Medical Center, to complete any missing work.
Extension data from the SUSTAIN and STEP programs show a stable safety profile out to two years of continuous use. The 2023 SELECT trial reported a 20 percent drop in major cardiovascular events among adults with overweight or obesity and established heart disease - support for sustained treatment beyond weight loss alone.
Yes. Semaglutide (as Ozempic) is FDA-approved for blood-sugar control in type 2 diabetes and widely prescribed by telehealth clinicians serving Houston. For patients with both diabetes and obesity it addresses both at once. Share every current medication during your assessment so the physician can check interactions.
Four steps: complete a 10 to 15 minute online assessment; a licensed Texas physician reviews it within 24 hours; if approved, the prescription goes to a 503B pharmacy; and medication ships to your Houston address. No in-person visit is required under Texas Occupations Code §111.001 - the reason it works for offshore, night and turnaround schedules.
Most Houston patients get their prescription within 24 to 48 hours of finishing the assessment, with overnight temperature-controlled shipping after approval. Even out in ZIP codes 77001, 77002, 77003, 77004, 77005, delivery usually lands within one to two business days - no waiting for a daytime appointment.
Your visit covers a review of the health assessment, your history and current medications, BMI and any related conditions, and the semaglutide dosing plan, ending in a prescription when appropriate. Dr. David Park, MD, Board-Certified Internal Medicine & Obesity Medicine, oversees clinical review for Houston patients - the same rigor as an in-person consult, on your schedule.
Semaglutide for weight management is a once-weekly subcutaneous injection from a pre-filled pen. You start at 0.25 mg weekly for four weeks and step up over 16 to 20 weeks to a 2.4 mg maintenance dose. Instructions ship with the first order; most Houston patients self-inject easily, and the care team walks you through the first one.
Keep unopened pens refrigerated at 36 to 46 F. After first use, a pen can sit at room temperature up to 77 F for 28 days. Don't freeze it or leave it in direct sun. Given Houston's heat and humidity, make sure someone is home to refrigerate summer deliveries promptly.
Texas carries an uninsured rate of 16.6%, among the highest in the country, driving strong demand for affordable cash-pay options. For contract energy workers and others between coverage, a telehealth semaglutide program at $199–$379/month is a realistic alternative to clinic-based care in Houston.
The draw in Houston is simple: no shift sacrificed to a waiting room, no Loop or I-10 traffic to a clinic, real privacy, costs you can predict at $199–$379/month, and no insurance prior-auth delay. For people on rotations and nights, getting care that bends around the schedule - not the other way around - is the deciding factor.
GLP-1 (glucagon-like peptide-1) is an incretin hormone released by intestinal L-cells after meals. GLP-1 receptor agonists are engineered drugs that copy and strengthen that signal, used for type 2 diabetes and, at higher doses, chronic weight management. Telehealth has widened access to this therapy for Houston residents since 2022.
Semaglutide is the active molecule. Ozempic (0.5 to 2 mg weekly) is approved for type 2 diabetes; Wegovy (2.4 mg weekly) is approved for weight management; both are Novo Nordisk brands of semaglutide. Compounded semaglutide carries the same active ingredient at lower cost through licensed telehealth providers in TX.
Compounded semaglutide is not an FDA-approved product, but it is legally made by FDA-registered 503B outsourcing facilities under Section 503B of the FD&C Act. The FDA issued shortage-related compounding guidance in 2024 to 2025. TX-licensed prescribers may order compounded semaglutide when medically appropriate for Houston patients.
Rybelsus (oral semaglutide, 7 to 14 mg daily) is approved for type 2 diabetes and has lower bioavailability than the injection. For weight management, the 2.4 mg weekly injection (Wegovy) or compounded injectable semaglutide is the standard. TX telehealth providers can prescribe either based on preference and clinical fit.
The standard ramp is 0.25 mg weekly for four weeks, then 0.5, 1.0, 1.7 and finally 2.4 mg weekly, each step about four weeks. Houston patients hitting strong GI effects can move more slowly - flexibility that helps when nausea would otherwise collide with a demanding shift.
STEP-1 participants averaged 14.9 percent body-weight loss over 68 weeks on semaglutide 2.4 mg weekly. Real-world results for Houston patients who complete the full 16-to-20-week titration generally fall between 8 and 20 percent, depending on adherence, diet and starting BMI.
All clinical content here is reviewed by Dr. David Park, MD, Board-Certified Internal Medicine & Obesity Medicine, licensed in Texas. Prescriptions issue only after a licensed Texas physician reviews your assessment. The program follows Texas Occupations Code §111.001 and Texas Medical Board standards - the same accountability you'd expect from a Houston clinic, delivered online.
GLP-1 Telehealth Houston connects Houston residents with licensed physicians for FDA-regulated GLP-1 therapy, with a focus on people whose work hours don't fit standard clinic schedules. Our team specializes in metabolic and weight-management telehealth. Medical Director: Dr. David Park, MD, Board-Certified Internal Medicine & Obesity Medicine. We serve patients across Houston and the surrounding metro.
Medical Director: Dr. David Park, MD, Board-Certified Internal Medicine & Obesity Medicine. Licensed in Texas. All prescriptions issued under Texas Occupations Code §111.001 and supervised by Texas Medical Board.